Stryker Corp SYK

Revenue Intelligence Report • 70 quarters of SEC filing data • Updated 2026-03-15

Revenue growth is driven by a combination of product demand and spending efficiency, with SG&A delivering a higher revenue elasticity (0.78% per 1% increase) than R&D (0.45% per 1% increase) in a log-log model built on 70 quarters of data. The model shows reasonably accurate forecasting, with a 3.8% MAPE and a holdout error of 5.3% (predicted 6.8B vs actual 7.2B), indicating useful but imperfect quarterly predictability. The FY outlook projects about $27B in revenue, up roughly 7.5% year over year, signaling a constructive growth path supported by durable product demand and efficient expense translation. For investors, ROI appears more favorable from SG&A investments driving near-term revenue uplift, while preserving R&D productivity remains important to sustain longer-term, competitive growth.

Investment Thesis

The econometric model achieves strong accuracy (3.8% MAPE), suggesting Stryker Corp's revenue trajectory is well-characterized by its spending patterns. R&D investment shows a 0.45x multiplier — each 1% increase in R&D spend is associated with a 0.45% revenue increase, signaling strong innovation-to-revenue conversion. Sales & marketing spend shows a 0.78x elasticity, suggesting effective go-to-market execution.

Next FY Revenue
$27.0B
+7.5% YoY
R&D Elasticity
0.45x
SG&A Elasticity
0.78x
Model Accuracy
3.8% MAPE
Holdout validation: The model predicted $6.8B vs the actual $7.2B — an error of 5.3%.

Revenue Forecast

SYK Revenue Forecast

Quarterly Detail

QuarterModel ForecastActual95% RangeYoY GrowthStatus
Q4 2025 $6.8B $7.2B $6.1B – $7.6B +5.6% ✓ In range
Q2 2026 $6.4B $5.5B – $7.6B +9.4%
Q3 2026 $6.6B $5.4B – $8.1B +9.9%
Q4 2026 $6.7B $5.3B – $8.4B +10.6%
Q1 2027 $7.3B $5.6B – $9.4B +1.3%

Seasonal Factors

Multiplicative seasonal adjustment: These factors capture Stryker Corp's systematic quarterly revenue patterns relative to the trend model. A factor of 1.05 means that quarter typically runs 5% above the underlying trend; 0.95 means 5% below. Factors are computed as the median of (actual / fitted) across all available quarters.
Fiscal QuarterSeasonal Factorvs TrendInterpretationObs.
FQ1 (Sep–Nov) 0.9826 -1.7% In line with trend 17
FQ2 (Dec–Feb) 1.0379 +3.8% +3.8% above trend 17
FQ3 (Mar–May) 0.9845 -1.5% In line with trend 16
FQ4 (Jun–Aug) 0.9912 -0.9% In line with trend 16

How Spending Drives Revenue

SYK Spending Timing
Reading this chart: Each line shows the cumulative elasticity — how a 1% increase in spending translates to revenue growth over subsequent quarters. The effect builds over 4-5 quarters as investments compound.

Want this analysis for your portfolio?

I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.

Get in Touch

Data sourced from SEC EDGAR XBRL filings. Model: ARDL (log-log) with 70 quarters. This analysis is for informational purposes only and does not constitute investment advice.

More in Healthcare

BAX HUM IQV GEHC ABBV MDT INCY BIIB